Topic: Health and Medicine
Recipient of the 9th Annual Heinz Award for the Human Condition, Paul Farmer is a medical doctor and a professor of anthropology at Harvard's Medical School. He shuttles between Harvard and Haiti, where he maintains a practice at Clinique Bon Saveur, a charity hospital he founded. Farmer talks in this audio interview with Globeshakers host Tim Zak about the challenges and rewards of providing health care to the poorest of the poor, and the evolving, innovative models for getting drugs to those who need them most.
Dr. Moira Gunn talks about the latest in brain surgery with neurosurgeon Dr. Katrina Firlik. Dr. Firlik is the author of the book "Another Day in the Frontal Lobe."
Dr. Moira Gunn speaks with Robert "Al" Beardsley, the President and CEO of Kereos. He talks about their cancer research -- and how it fits in the field of nanotech. Then on the BioIssue of the Week, David Duncan will give us the expert's view on a reasonable timeline to expect results from today's stem cell research.
On BioTech Nation, Dr. Moira Gunn speaks with Dr. Mahendra Rao, the Vice President of Research in Regenerative Medicine and Stem Cell Technologies for Invitrogen. He'll tell us how a stem cell line dies out, and what this means for the Presidential Stem Cell Lines, the only ones approved for federal funding. Then on the BioIssue of the Week, we'll find out why the 2004
California Stem Cell Initiative appears to be in limbo.
The China Project offers a rare opportunity to study disease in a precise manner because of the unique conditions that exist in rural China. For example, about 90% of the people in rural China live their entire lives in the vicinity of their birth. They also consume diets composed primarily of locally produced foods. These factors make rural China a living laboratory for the study of the complex relationship between nutrition and other lifestyle factors and degenerative diseases.
On BioTech Nation, Dr. Moira Gunn speaks with Anne De Groot, the Founder & CEO of EpiVax, about smallpox, botox, and more. And for the BioIssue of the Week, science journalist David Ewing Duncan talks about the personalities of scientists.
Dr. Moria Gunn speaks with Michael Morrissey, Executive Vice President for Drug Discovery at Exelixis, talks about their efforts in discovering new drugs for cancer research. And BioIssue of the Week, science journalist David Ewing Duncan talks about the economics of the biotech industry.
On this edition of Tech Nation, Dr. Moira Gunn speaks with Dr Rubin Naiman, the sleep and dream medicine specialist in Dr. Andy Weil's Program in Integrative Medicine. His book is "Healing Night: The Science and Spirit of Sleeping, Dreaming and Awakening."
In today's world, we routinely implant heart pacemakers and replace knee and hip joints. Are we fast becoming part machine? How far can we go? Find out as Dr. Moira Gunn speaks with Dr. Greg Stock, the Director of UCLA's Program on Medicine, Technology and Society and CEO, Signum Biosciences.
Dr. Moira Gunn speaks with Dr. Corey Goodman, the president and CEO of Renovis, who gives us some perspective on regenerative medicine and the ethics of the scientific community.
